| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |